Humira biosimilars catch fire in Europe and could take half the market in a year: report
admin 25th January 2019 Uncategorised 0The mass exodus from AbbVie’s Humira to biosimilars confirms what AbbVie’s executives have already admitted, which is that their initial estimate of a 20% revenue loss in Europe by 2020 was way too optimistic. More: Humira biosimilars catch fire in
read more